Abstract
Glucagon suppression by somatostatin reduces or abolishes hyperglycemia in dogs made insulin-deficient by somatostatin, alloxan, or total pancreatectomy. This suggests that the development of severe diabetic hyperglycemia requires the presence of glucagon, whether secreted by pancreatic or newly identified gastrointestinal A cells, as well as a lack of insulin. Glucagon suppression could improve therapeutic glucoregulation in diabetes.
Original language | English (US) |
---|---|
Pages (from-to) | 544-547 |
Number of pages | 4 |
Journal | Science |
Volume | 187 |
Issue number | 4176 |
DOIs | |
State | Published - 1975 |
ASJC Scopus subject areas
- General